COMMUNIQUÉS West-GlobeNewswire

ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
06/08/2026
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
06/08/2026
Conference Call Scheduled for Friday, August 14, 2026 at 9:00 AM ET PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics [...]
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
06/08/2026
CANTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, [...]
Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results
06/08/2026
Reported topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial; Topline data from 400-person sentinel safety cohort and approximately 5,000 participants in main cohort anticipated in first half of [...]
Structure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
06/08/2026
First patients dosed in aleniglipron (oral small molecule GLP-1 receptor agonist) Phase 3 ACCOMPLISH program for chronic weight management Data from Phase 1 SAD clinical trial of ACCG-2671 (oral small molecule dual [...]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026
06/08/2026
PiNACLE pivotal clinical trial evaluating ronde-cel in 3L+ patients with LBCL on track to report additional data in second half of 2026, with pivotal data expected mid-2027 and BLA submission expected to follow in the [...]
Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update
06/08/2026
Q2 2026 total product revenue of $118.1 million, reflecting 31% growth year-over-year IBSRELA Q2 2026 revenue growth of 33% year-over-year to $86.2 million XPHOZAH Q2 2026 revenue growth of 27% year-over-year to $31.9 [...]
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
06/08/2026
Q4 revenue increased by 9% to a record $1.5 billion; up 8% on a constant currency basis Q4 GAAP diluted earnings per share up 2% to $2.64; non-GAAP diluted earnings per share up 16% to $2.95 Returned $1.0 billion to [...]
Caring Brands Provides Intellectual Property Portfolio Update
06/08/2026
Commercial Patent Portfolio Includes Five Issued U.S. Patents Protecting Core Flagship Platforms Targeting $20B+ Combined Global Dermatology & Hair Care Markets Fort Pierce, FL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- [...]
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
06/08/2026
Clinical, safety and translational data presented at EULAR 2026 reinforced AlloNK ® ’s potential to drive deep B-cell depletion and meaningful clinical activity, with a tolerability profile supportive of outpatient [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
06/08/2026
CONSHOHOCKEN, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
SkinHealth Systems Reports Second Quarter 2026 Financial Results
06/08/2026
LONG BEACH, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second [...]
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
06/08/2026
Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of enrollment expected in 2027. Bimatoprost-Drug Ring System (BIM-DRS) first-in- [...]
Tango Therapeutics Announces Executive Chair Transition
07/08/2026
BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today [...]
Biogen Completes Acquisition of RayThera Inc.
07/08/2026
Lead program now in Phase 1 development CAMBRIDGE, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the completion of the acquisition of RayThera Inc., a privately held biotechnology [...]
BioStem Technologies Announces Nasdaq Uplisting
06/08/2026
Trading to Commence on August 7, 2026 POMPANO BEACH, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the [...]
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
06/08/2026
BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 [...]
VitalHub Announces Normal Course Issuer Bid
06/08/2026
TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (“VitalHub” or the “Company”) announced today that the Toronto Stock Exchange (the "Exchange") has accepted a notice filed by VitalHub of [...]
VitalHub Reports Second Quarter 2026 Results
06/08/2026
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 28% YoY to $101.5 million Total Revenue up 33% YoY to $31.7 million Adjusted EBITDA⁽¹⁾ up 29% YoY to $8.2 million TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI [...]

Pages